Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04476732 · ClinicalTrials.gov registry record · NA
Interactions Between Skincare Product Ingredients and the Skin Microbiome
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT04476732: Completed NA study, sponsored by University of California, Davis.
NCT04476732 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04476732, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
This is a study of the influence of skincare products containing chemicals such as parabens and phthalates on the skin microbiome.
Primary Outcome
Demonstrate the ability to detect chemicals (specifically parabens) found in common ingredients in personal care products on human skin. Collection of isopropyl alcohol forehead wipe and subsequent detection and quantification of parabens by GC-QTOF-MS (gas chromatography) and LC-QTOF-MS (liquid chromatography). Comparisons between baseline, week 1, and week 2 will be made.
Interventions
- OTHER Paraben-free skincare product
- OTHER Paraben-containing skincare product
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2020-02-11 |
| Est. Completion | 2020-07-16 |
| Phase | NA |
What the finished NCT04476732 record still lists
NCT04476732 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Paraben-free skincare product is the first listed.
NCT04476732 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04476732 about?
NCT04476732 is a clinical study titled "Interactions Between Skincare Product Ingredients and the Skin Microbiome". This is a study of the influence of skincare products containing chemicals such as parabens and phthalates on the skin microbiome.
What is the current status of trial NCT04476732?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2020-02-11. Estimated completion is 2020-07-16.
What interventions are being tested in trial NCT04476732?
The interventions under investigation include: Paraben-free skincare product (OTHER), Paraben-containing skincare product (OTHER).
Who is sponsoring clinical trial NCT04476732?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04476732's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI